NEWS

Ángel Chamorro interview - The CHOICE Randomized Clinical Trial

ACom Aneurysm Recurrence treated with Flow diverter

Tandem occlusion with workflow issue

Incidental distal PICA Aneurysm treated with FD

Vesalio Announces Earl Slee as New Board Observer and Senior Advisor to...

Nashville, TN (February 3, 2022) – Vesalio is pleased to announce the addition of Earl Slee as a board observer and senior advisor to the company, effective immediately.

Recanalized Acom Aneurysm Robotic Treatment.

Vesalio Announces Appointment of Mike Kujak as its New Independent Board...

Nashville, TN, January 19, 2022 – Vesalio is pleased to announce the appointment of Mike Kujak as chairman of its Board of Directors. In this role, Mike will bring expert knowledge and know-how from his years of leadership in the medical device start-up space.

Incidental ACom Aneurysm with intrasaccular FD device

MCA severe stenosis management

Wallaby Medical launches Avenir® Coil System for hemorrhagic stroke trea...

SHANGHAI, CHINA – December 27, 2021 -  Wallaby Medical (“Wallaby”), a rapidly growing medical device company focused on developing and commercializing medical device products for treating stroke has partnered with Japan Lifeline Co., Ltd. (“JLL”), a publicly-listed medical device manufacturer and distributor with 48 sales offices across Japan, to bring Wallaby’s Japan PMDA approved Avenir® Coil System to the Japanese market. Avenir is used in the intravascular embolization of intracranial aneurysms and other neurovascular malformations (such as arteriovenous malformations and arteriovenous fistulas), as well as arterial and venous embolization of peripheral blood vessels.